June 30 (Reuters) - 9 Meters Biopharma Inc NMTR.O :
* 9 METERS BIOPHARMA-ON JUNE 30, ENTERED INTO SECURITIES
PURCHASE
AGREEMENT FOR PURCHASE OF SENIOR SECURED CONVERTIBLE NOTES WITH
INSTITUTIONAL INVESTOR
* 9 METERS BIOPHARMA- PRINCIPAL AMOUNT FOR INITIAL NOTE IS
EXPECTED TO BE $21 MILLION WITH OPTION TO ISSUE ADDITIONAL
CONVERTIBLE NOTES OF UP TO $70 MILLION
* 9 METERS BIOPHARMA INC - ANNOUNCES DEBT FACILITY TO
SUPPORT
PHASE 3 STUDY OF VUROLENATIDE FOR SHORT BOWEL SYNDROME
* 9 METERS BIOPHARMA INC - INITIAL DRAW OF $20 MILLION TO
SUPPORT
FUNDING PHASE 3 DEVELOPMENT OF VUROLENATIDE IN SHORT BOWEL
SYNDROME
Further company coverage: NMTR.O